Kaiser L - Search Results

1

Reduced Acquisition Time [¹⁸F]GE-180 PET Scanning Protocol Replaces Gold-Standard Dynamic Acquisition in a Mouse Ischemic Stroke Model.

Zatcepin A, Heindl S, Schillinger U, Kaiser L, Lindner S, Bartenstein P, Kopczak A, Liesz A, Brendel M, Ziegler SI. Zatcepin A, et al. Among authors: kaiser l. Front Med (Lausanne). 2022 Feb 10;9:830020. doi: 10.3389/fmed.2022.830020. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35223925 Free PMC article.

2

Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging.

Schirrmacher R, Bailey JJ, Mossine AV, Scott PJH, Kaiser L, Bartenstein P, Lindner S, Kaplan DR, Kostikov A, Fricker G, Mahringer A, Rosa-Neto P, Schirrmacher E, Wängler C, Wängler B, Thiel A, Soucy JP, Bernard-Gauthier V. Schirrmacher R, et al. Among authors: kaiser l. Pharmaceuticals (Basel). 2019 Jan 3;12(1):7. doi: 10.3390/ph12010007. Pharmaceuticals (Basel). 2019. PMID: 30609832 Free PMC article. Review.

3

In response to: The validity of ¹⁸F-GE180 as a TSPO imaging agent.

Albert NL, Unterrainer M, Brendel M, Kaiser L, Zweckstetter M, Cumming P, Bartenstein P. Albert NL, et al. Among authors: kaiser l. Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1208-1211. doi: 10.1007/s00259-019-04294-8. Epub 2019 Mar 2. Eur J Nucl Med Mol Imaging. 2019. PMID: 30826897 Free article. No abstract available.

4

First-in-Human Brain Imaging of [¹⁸F]TRACK, a PET tracer for Tropomyosin Receptor Kinases.

Bailey JJ, Kaiser L, Lindner S, Wüst M, Thiel A, Soucy JP, Rosa-Neto P, Scott PJH, Unterrainer M, Kaplan DR, Wängler C, Wängler B, Bartenstein P, Bernard-Gauthier V, Schirrmacher R. Bailey JJ, et al. Among authors: kaiser l. ACS Chem Neurosci. 2019 Jun 19;10(6):2697-2702. doi: 10.1021/acschemneuro.9b00144. Epub 2019 Apr 29. ACS Chem Neurosci. 2019. PMID: 31017386

5

Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer's disease tau.

Brendel M, Deussing M, Blume T, Kaiser L, Probst F, Overhoff F, Peters F, von Ungern-Sternberg B, Ryazanov S, Leonov A, Griesinger C, Zwergal A, Levin J, Bartenstein P, Yakushev I, Cumming P, Boening G, Ziegler S, Herms J, Giese A, Rominger A. Brendel M, et al. Among authors: kaiser l. Alzheimers Res Ther. 2019 Aug 1;11(1):67. doi: 10.1186/s13195-019-0522-z. Alzheimers Res Ther. 2019. PMID: 31370885 Free PMC article.

6

3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CT.

Gosewisch A, Ilhan H, Tattenberg S, Mairani A, Parodi K, Brosch J, Kaiser L, Gildehaus FJ, Todica A, Ziegler S, Bartenstein P, Böning G. Gosewisch A, et al. Among authors: kaiser l. EJNMMI Res. 2019 Aug 14;9(1):76. doi: 10.1186/s13550-019-0548-z. EJNMMI Res. 2019. PMID: 31414241 Free PMC article.

7

TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative ¹⁸F-GE-180 PET study.

Unterrainer M, Fleischmann DF, Vettermann F, Ruf V, Kaiser L, Nelwan D, Lindner S, Brendel M, Wenter V, Stöcklein S, Herms J, Milenkovic VM, Rupprecht R, Tonn JC, Belka C, Bartenstein P, Niyazi M, Albert NL. Unterrainer M, et al. Among authors: kaiser l. Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1368-1380. doi: 10.1007/s00259-019-04491-5. Epub 2019 Sep 5. Eur J Nucl Med Mol Imaging. 2020. PMID: 31486876

8

Toxicity of a combined therapy using the mTOR-inhibitor everolimus and PRRT with [¹⁷⁷Lu]Lu-DOTA-TATE in Lewis rats.

Zellmer J, Yen HY, Kaiser L, Mille E, Gildehaus FJ, Böning G, Steiger K, Hacker M, Bartenstein P, Todica A, Haug AR, Ilhan H. Zellmer J, et al. Among authors: kaiser l. EJNMMI Res. 2020 Apr 25;10(1):41. doi: 10.1186/s13550-020-00628-y. EJNMMI Res. 2020. PMID: 32335736 Free PMC article.

9

In response to: Anatomy of ¹⁸F-GE180, a failed radioligand for the TSPO protein.

Albert NL, Unterrainer M, Kaiser L, Brendel M, Vettermann FJ, Holzgreve A, Bartenstein P. Albert NL, et al. Among authors: kaiser l. Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2237-2241. doi: 10.1007/s00259-020-04885-w. Epub 2020 Jun 10. Eur J Nucl Med Mol Imaging. 2020. PMID: 32524162 Free PMC article. No abstract available.

10

TSPO PET With 18F-GE-180 to Differentiate Variants of Multiple Sclerosis: Relapsing-Remitting Multiple Sclerosis, Tumefactive Demyelination, and Baló's Concentric Sclerosis.

Völk S, Unterrainer M, Albert NL, Havla J, Gerdes LA, Schumacher M, Brendel M, Kaiser L, Adorjan K, Rupprecht R, Bartenstein P, Kümpfel T, Danek A. Völk S, et al. Among authors: kaiser l. Clin Nucl Med. 2020 Oct;45(10):e447-e448. doi: 10.1097/RLU.0000000000003220. Clin Nucl Med. 2020. PMID: 32796248

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,574 results

Search Page

Filters